4 results
Approved WMOCompleted
To compare OS in patients with previously untreated Stage IIIc, N3 (unresectable) or Stage IV melanoma receiving dacarbazine plus 10mg/kg ipilimumab (MDX-010) vs. dacarbazine with placebo.
Approved WMOCompleted
PRIMARY OBJECTIVE The primary objective of this study is to evaluate the effect of ALN-PCSSC treatment on LDL-C levels at Day 180. SECONDARY OBJECTIVESThe secondary objectives of this study are to evaluate the effect of ALN-PCSSC on the following…
Approved WMORecruiting
The main objective is to study the efficacy of treatment with RTX in patients with relapsing PMR compared to placebo.
Approved WMORecruiting
The main objective is to study the efficacy of treatment with RTX in patients with newly diagnosed PMR compared to placebo.